Arcus Biosciences Inc (RCUS) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

Arcus Biosciences Inc (Arcus Biosciences) is a clinical stage bio-pharmaceutical company. It develops and provides cancer immunotherapies. Its products pipeline includes AB928 that is in phase 1 clinical trial; AB122 developed for cancer patients that is in phase 1 clinical trial; AB680 a CD73 inhibitor; and AB154 a monoclonal antibody. The company offers its products for the treatment in various medical areas including immunology, medicinal chemistry, biochemistry, enzymology, pharmacology and structural biology. Arcus Biosciences is headquartered in Hayward, California, the US.

Arcus Biosciences Inc (RCUS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

it derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.



List of Tables 4
List of Figures 4
Arcus Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Arcus Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Arcus Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Arcus Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Arcus Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Arcus Biosciences Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Arcus Biosciences Raises USD107 Million in Series C Financing 10
Arcus Biosciences Raises USD70 Million in Series B Financing 12
Arcus Biosciences Raises USD50 Million in Series A Financing 13
Partnerships 15
Arcus Biosciences and Infinity Pharma Enter into Clinical Collaboration Agreement 15
Licensing Agreements 16
Taiho Pharma Enters into Licensing Agreement with Arcus Biosciences 16
Arcus Biosciences Enters into Licensing Agreement with Wuxi Biologics and Harbin Gloria Pharma for GLS-010 17
Arcus Biosciences Enters into Licensing Agreement with Abmuno Therapeutics 18
Equity Offering 19
Arcus Biosciences Raises USD138 Million in IPO 19
Arcus Biosciences Inc - Key Competitors 20
Arcus Biosciences Inc - Key Employees 21
Arcus Biosciences Inc - Locations And Subsidiaries 22
Head Office 22
Recent Developments 23
Financial Announcements 23
Aug 06, 2018: Arcus Biosciences announces second quarter 2018 financial results and recent corporate updates 23
May 09, 2018: Arcus Biosciences Announces First Quarter 2018 Financial Results and Recent Corporate Updates 25
Corporate Communications 27
Jun 12, 2018: Arcus Biosciences Announces the Promotion of Jennifer Jarrett to Chief Operating Officer 27
Dec 18, 2017: Arcus Biosciences Appoints David Beier to Board of Directors 28
Sep 18, 2017: Arcus Biosciences Appoints Kate Falberg to Its Board of Directors 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List Of Tables


Arcus Biosciences Inc, Pharmaceuticals & Healthcare, Key Facts 2
Arcus Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Arcus Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Arcus Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Arcus Biosciences Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Arcus Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Arcus Biosciences Raises USD107 Million in Series C Financing 10
Arcus Biosciences Raises USD70 Million in Series B Financing 12
Arcus Biosciences Raises USD50 Million in Series A Financing 13
Arcus Biosciences and Infinity Pharma Enter into Clinical Collaboration Agreement 15
Taiho Pharma Enters into Licensing Agreement with Arcus Biosciences 16
Arcus Biosciences Enters into Licensing Agreement with Wuxi Biologics and Harbin Gloria Pharma for GLS-010 17
Arcus Biosciences Enters into Licensing Agreement with Abmuno Therapeutics 18
Arcus Biosciences Raises USD138 Million in IPO 19
Arcus Biosciences Inc, Key Competitors 20
Arcus Biosciences Inc, Key Employees 21

List Of Figures


Arcus Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Arcus Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Arcus Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Arcus Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Arcus Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Arcus Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Arcus Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Arcus Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Arcus Biosciences Inc (RCUS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Arcus Biosciences Inc (Arcus Biosciences) is a clinical stage bio-pharmaceutical company. The company develops and commercializes cancer immunotherapies. Its product pipeline includes AB928, which is in phase 1/1b trial;

USD 250 View Report

Arcus Biosciences Inc (RCUS) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Arcus Biosciences Inc (Arcus Biosciences) is a clinical stage bio-pharmaceutical company. It develops and provides cancer immunotherapies. Its products pipeline includes AB928 that is in phase 1 clinical trial; AB122

USD 250 View Report

Akers Biosciences Inc (AKER) - Product Pipeline Analysis, 2019 Update

Akers Biosciences Inc (ABI) is a medical device company that develops, manufactures and supplies point-of-care screening and testing products. The company provides clinical diagnostics, safety diagnostics, and wellness products. Its

USD 750 View Report

Angle Biosciences Inc - Product Pipeline Analysis, 2019 Update

Angle Biosciences Inc (Angle Biosciences), formerly Axela Inc, is a provider of optic technology solutions. The company offers Ziplex system, Flow-thru TipChips, panelPlus TipChips, diffractive optics technology, diffractive optics sensors,

USD 750 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available